Genetic testing for melanoma predisposition: current challenges.

Cancer nursing

Volumn 30, Issue 6, 2007, Pages

  Gerstenblith, Meg R ^a   Goldstein, Alisa M ^a   Tucker, Margaret A ^a   Fraser, Mary C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; UNCLASSIFIED DRUG;

COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; MELANOMA; PENETRANCE; REVIEW; TUMOR SUPPRESSOR GENE;

COST-BENEFIT ANALYSIS; CYCLIN-DEPENDENT KINASE 4; EVIDENCE-BASED MEDICINE; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MELANOMA; PENETRANCE;

EID: 38449095893     PISSN: None     EISSN: 15389804     Source Type: Journal    
DOI: None     Document Type: Review

References (54)